Key result
Platelet dense granule ATP release testing showed inconsistent findings in 36-39% of subjects tested multiple times, suggesting limited value for diagnosing platelet disorders.
Why the study?
Is lumi-aggregometry quantification of platelet dense granule ATP release a reliable diagnostic test for platelet function disorders?
Cohort (n=150)
Is lumi-aggregometry quantification of platelet dense granule ATP release a reliable diagnostic test for platelet function disorders?
Lumi-aggregometry for platelet dense granule ATP release shows significant intra-patient variability, limiting its diagnostic value for platelet disorders.
Answers are grounded in this paper and cite their sources.
High intra-patient variability cautions against relying on single ATP release tests for diagnosis; leaves open need for validated protocols or alternatives.
INTRODUCTION: Lumi-aggregometry quantification of platelet dense granule adenosine triphosphate (ATP) release is commonly used for diagnosing platelet function disorders. As the test findings show considerable variability for healthy controls, we postulated that patient findings might also be variable and investigated patients who were assessed for dense granule ATP release defects more than once. METHODS: Analyses were performed on prospectively collected data for first and second tests for subjects tested for dense granule ATP release defects more than once by the Hamilton Regional Laboratory Program (HRLMP) between January 2007 and June 2013 (cohort I). Similar analyses were performed for subjects who were recruited to a platelet disorder study (cohort II) and were assessed for ATP release defects more than once before October 2015. RESULTS: A total of 150 unique subjects had multiple ATP release tests. Results with individual agonists were variable for many subjects. While normal findings with all tested agonists were often confirmed by the second test (cohort I: 83%; cohort II: 100%), impaired release with multiple agonists was confirmed in only some subjects (cohort I: 34%; cohort II: 54%). Inconsistent findings were common (cohort I: 36%; cohort II: 39%). ISTH bleeding scores showed no relationship to the test findings. The finding of impaired ATP release with 2 or more agonists on both tests was not associated with an increased likelihood of a definite bleeding disorder. CONCLUSION: The variability in platelet dense granule ATP release findings amongst patients assessed for diagnostic purposes suggests that the test has limited value for diagnosing platelet disorders.
No takes yet. Share an insight, caveat, or question.
Badin et al. (2016) conducted a cohort in Bleeding disorder (n=150). Multiple platelet dense granule ATP release tests was evaluated on Consistency of ATP release findings between first and second tests. Platelet dense granule ATP release testing showed inconsistent findings in 36-39% of subjects tested multiple times, suggesting limited value for diagnosing platelet disorders.
Synapse has enriched 10 related papers. Consider them for comparative context: